Clearbridge Health has received its first batch of the Sinopharm Covid-19 Vaccine here in Singapore.
On Aug 9, the company announced it would be buying the vaccine directly from its manufacturers in China for use in Singapore.
The Sinopharm COVID-19 Vaccine has been authorised for conditional or emergency use in several countries including China, UAE, Malaysia, Thailand and Indonesia.
It has also been listed by the WHO for emergency use.
Medic Surgical & Laser Clinic, operated by a Clearbridge Health subsidiary, has been granted approval under the Health Sciences Authority of Singapore's Special Access Route scheme to import and supply the Sinopharm COVID-19 Vaccine in Singapore for six months from July 6.
Clearbridge shares closed Aug 27 at 12 cents, down 1.64% for the day and down 20% year to date.
